BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7373890)

  • 1. [Rapid measurement of fibrinolytic activity in CSF by t-AMCA score method. Correlation with concentration of antifibrinolytic agent in CSF (author's transl)].
    Nishimatsu T; Shibasaki T; Sasaki H; Nukui H; Kawafuchi J; Okada K
    Rinsho Byori; 1980 Mar; 28(3):265-70. PubMed ID: 7373890
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic activity in CSF of patients with SAH in the acute phase measured by a rapid method (correlation with t-AMCA concentration in CSF.
    Nishimatsu T; Shibasaki T; Sasaki H; Nukui H
    Neurol Med Chir (Tokyo); 1981 Jan; 21(1):85-93. PubMed ID: 6168953
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinolytic activity of cerebrospinal fluid in subarachnoid hemorrhage (author's transl)].
    Imanaga H; Osugi T; Kagawa M; Kita-Mura K
    No Shinkei Geka; 1977 Jan; 5(1):51-8. PubMed ID: 557178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.
    Fodstad H
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():68-73. PubMed ID: 7000850
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolytic changes in subarachnoid hemorrhage and anti-fibrinolytic therapy--application of an anti-plasmin agent (t-AMCHA)].
    Watanabe H; Ishii S; Chigasaki H
    Nihon Rinsho; 1978; 36(3):555-62. PubMed ID: 650932
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).
    Fodstad H; Nilsson IM
    Acta Neurochir (Wien); 1981; 56(1-2):25-38. PubMed ID: 7195642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental studies on the diffusion of antifibrinolytic agents in fibrin thrombi. A contribution to intrathecal antifibrinolytic therapy in subarachnoid hemorrhages].
    Hindersin P; Senf L; Richter M; Endler S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):313-8. PubMed ID: 6179834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ulcerative colitis by the direct administration of an antifibrinolytic agent as an enema.
    Kondo M; Hotta T; Takemura S; Yoshikawa T; Fukumoto K
    Hepatogastroenterology; 1981 Oct; 28(5):270-3. PubMed ID: 7047340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid.
    Tsementzis SA; Honan WP; Nightingale S; Hitchcock ER; Meyer CH
    Acta Neurochir (Wien); 1990; 103(3-4):116-21. PubMed ID: 2205078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of tranexamic acid, AMCA for the improvement of hemorrhagic manifestations in hemophilia.
    Donner L; Klener P
    Vnitr Lek; 1971 Sep; 17(9):846-50. PubMed ID: 5129130
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of antifibrinolytica on traumatic hyphaema and corneal oedema.
    Bramsen T
    Acta Ophthalmol Suppl; 1980; (145):1-53. PubMed ID: 6257028
    [No Abstract]   [Full Text] [Related]  

  • 13. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy.
    Woo KS; Tse LK; Woo JL; Vallance-Owen J
    Br J Clin Pract; 1989 Dec; 43(12):465-6. PubMed ID: 2611113
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.
    Fodstad H; Pilbrant A; Schannong M; Strömberg S
    Acta Neurochir (Wien); 1981; 58(1-2):1-13. PubMed ID: 7282453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of tranexamic acid.
    Astedt B
    Scand J Gastroenterol Suppl; 1987; 137():22-5. PubMed ID: 3321402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood.
    Watanabe H; Ito M; Chigasaki H; Ishii S
    Neurol Med Chir (Tokyo); 1976; 16(PT1):91-6. PubMed ID: 66644
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinolytic activity of cerebral tissue after experimental subarachnoid haemorrhage: inhibitory effect of tranexamic acid (AMCA).
    Fodstad H; Kok P; Algers G
    Acta Neurol Scand; 1981 Jul; 64(1):29-46. PubMed ID: 7198859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tissue fibrinolysis in the digestive mucosa. III. Treatment of ulcerative colitis by the direct administration of an antifibrinolytic agent as an enema (author's transl)].
    Kondo M; Fukumoto K; Yoshikawa T; Takemura S; Hotta T; Sugihara M; Furukawa Y; Matsuura S; Natsu K
    Nihon Shokakibyo Gakkai Zasshi; 1981 Mar; 78(3):653-7. PubMed ID: 7253294
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinolysis in surgery : personal experience with chest operations.
    Aguilar HD
    Indian J Chest Dis; 1974 Sep; 16 Suppl():310-21. PubMed ID: 4442936
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antifibrinolytic therapy of subarachnoid hemorrhage. Permeation of oral paraaminomethylbenzoic acid in the cerebrospinal fluid].
    Hindersin P; Heidrich R; Endler S
    Psychiatr Neurol Med Psychol (Leipz); 1980 Apr; 32(4):214-9. PubMed ID: 6968077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.